Deerfield Management launches $550M biotech fund, has impressive investor base and will turn some profits over to charity
With an impressive roster of backers, Deerfield Management is kicking off a $550 million biotech fund. It will invest in cancer, genetic and orphan diseases - and donate some of its profits to charity.